Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,014 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Using artificial intelligence to document the hidden RNA virosphere.
Hou X, He Y, Fang P, Mei SQ, Xu Z, Wu WC, Tian JH, Zhang S, Zeng ZY, Gou QY, Xin GY, Le SJ, Xia YY, Zhou YL, Hui FM, Pan YF, Eden JS, Yang ZH, Han C, Shu YL, Guo D, Li J, Holmes EC, Li ZR, Shi M. Hou X, et al. Among authors: yang zh. Cell. 2024 Nov 27;187(24):6929-6942.e16. doi: 10.1016/j.cell.2024.09.027. Epub 2024 Oct 9. Cell. 2024. PMID: 39389057 Free article.
GeneCompass: deciphering universal gene regulatory mechanisms with a knowledge-informed cross-species foundation model.
Yang X, Liu G, Feng G, Bu D, Wang P, Jiang J, Chen S, Yang Q, Miao H, Zhang Y, Man Z, Liang Z, Wang Z, Li Y, Li Z, Liu Y, Tian Y, Liu W, Li C, Li A, Dong J, Hu Z, Fang C, Cui L, Deng Z, Jiang H, Cui W, Zhang J, Yang Z, Li H, He X, Zhong L, Zhou J, Wang Z, Long Q, Xu P; X-Compass Consortium; Wang H, Meng Z, Wang X, Wang Y, Wang Y, Zhang S, Guo J, Zhao Y, Zhou Y, Li F, Liu J, Chen Y, Yang G, Li X. Yang X, et al. Cell Res. 2024 Dec;34(12):830-845. doi: 10.1038/s41422-024-01034-y. Epub 2024 Oct 8. Cell Res. 2024. PMID: 39375485 Free PMC article.
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Yang BF, et al. Among authors: yang zh. Expert Rev Vaccines. 2025 Dec;24(1):81-90. doi: 10.1080/14760584.2024.2446288. Epub 2025 Jan 5. Expert Rev Vaccines. 2025. PMID: 39720838 Free article.
1,014 results